Covance, Inc.
Covance announces record results, raises 2006 EPS target
Published in Pharma Investments, Ventures and Law Weekly, February 26th, 2006
This income tax charge of approximately 7 cents per share was associated with the repatriation of $103 million of accumulated foreign earnings under the American Jobs Creation Act. Full-year earnings on the same basis were $1.94/diluted share, a 27.6% increase over full-year 2004. Generally accepted accounting principles earnings for the fourth quarter ended December 31, 2005 were $0.47/diluted share and full-year earnings were $1.88/diluted share.
"I...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
More Articles from Pharma Investments, Ventures and Law Weekly
- BioSphere Medical, Inc.
Uterine fibroid treatment developer reports 20% revenue growth - Biomira, Inc.
Oncology company arranges $16.1M financing - Celgene Corp.
REVLIMID maker reports record operating performance for 2005 - Covalent Group, Inc.
Clinical trials company announces new business contracts with an aggregate value of $1M - Cubist Pharmaceuticals, Inc.
Cubicin maker reports Q4 full-year 2005 results; full-year loss per share totals 60 cents - Diamyd Medical AB
Diabetes therapy developer reports loss per share of SEK0.9 - More from this issue of Pharma Investments, Ventures and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
